Sol-Gel Technologies (SLGL) Other financing activities (2018 - 2023)

Sol-Gel Technologies' (SLGL) quarterly Other financing activities came in at $1.2 million in Q2 2023, up 1.48% year-on-year from $1.2 million in Q2 2022, and up 1.48% on a QoQ basis from $1.2 million in Q2 2022.

Sol-Gel Technologies (SLGL) Other financing activities (2018 - 2023) Analysis & Trends

Sol-Gel Technologies (SLGL) has 5 years of Other financing activities data on file, last reported at $1.2 million in Q2 2023.

  • On a quarterly basis, Other financing activities rose 1.48% year-over-year to $1.2 million in Q2 2023; TTM through Jun 2023 was $4.6 million, a 21.5% increase from a year earlier, with the FY2023 full-year figure at $268000.0, changed N/A from the prior year.
  • Other financing activities for Q2 2023 stood at $1.2 million, up from $1.2 million in the prior quarter.
  • Over the last five years, Other financing activities for SLGL reached as high as $1.2 million in Q2 2023 and fell as low as $1.2 million in Q2 2020.
  • Historically, Other financing activities has averaged $1.2 million across 4 years, with a median of $1.2 million in 2020.
  • Across the five-year window, Other financing activities changed 0.0% in 2021 and increased 1.48% in 2023, its largest moves.
  • Year by year, Other financing activities stood at $1.2 million in 2020, then changed by 0.0% to $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then gained by 1.48% to $1.2 million in 2023.
  • Per Business Quant data, the three most recent Other financing activities figures were $1.2 million in Q2 2023, $1.2 million in Q2 2022, and $1.2 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 1.17 Mn
Jun 30, 2023 1.17 Mn
Jun 30, 2022 1.15 Mn
Jun 30, 2022 1.15 Mn
Jun 30, 2021 1.15 Mn
Jun 30, 2021 1.15 Mn
Jun 30, 2020 1.15 Mn
Jun 30, 2020 1.15 Mn
Jun 30, 2018 350,000.00
Jun 30, 2018 350,000.00